Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization
about
The dengue virusesReplication of Colorado tick fever virus within human hematopoietic progenitor cellsNeutralizing antibodies after infection with dengue 1 virusLong-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern ThailandComparison of the Hemagglutination Inhibition Test and IgG ELISA in Categorizing Primary and Secondary Dengue Infections Based on the Plaque Reduction Neutralization TestDifferential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc RIA (CD64) or Fc RIIA (CD32)Primary and Secondary Infections of Macaca fascicularis Monkeys with Asian and American Genotypes of Dengue Virus 2Venezuelan Equine Encephalitis Virus in Iquitos, Peru: Urban Transmission of a Sylvatic StrainReliable Classifier to Differentiate Primary and Secondary Acute Dengue Infection Based on IgG ELISAAntibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different GenotypesImmunogenicity of a Psoralen-Inactivated Dengue Virus Type 1 Vaccine Candidate in MiceDengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact PerformanceDiscrepancy in Dengue Virus Neutralizing Antibody Titers between Plaque Reduction Neutralizing Tests with Fc Receptor (Fc R)-Negative and Fc R-Expressing BHK-21 CellsHigh frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central BrazilDengue: a continuing global threatScreening for immune response against Dengue virus in Vietnamese non-human primates: implications for vaccine developersEpidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission.West Nile virus infectious replicon particles generated using a packaging-restricted cell line is a safe reporter system.Antibody responses to Asian and American genotypes of dengue 2 virus in immunized miceAntiviral actions of flavanoid-derived compounds on dengue virus type-2Flow cytometry compared with indirect immunofluorescence for rapid detection of dengue virus type 1 after amplification in tissue culture.Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysisDetection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection.Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patientsThe diagnostic and prognostic value of dengue non-structural 1 antigen detection in a hyper-endemic region in Indonesia.Caveolin-1 in lipid rafts interacts with dengue virus NS3 during polyprotein processing and replication in HMEC-1 cells.Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development.Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil.Scanning mutagenesis studies reveal a potential intramolecular interaction within the C-terminal half of dengue virus NS2A involved in viral RNA replication and virus assembly and secretion.Dengue seroprevalence of healthy adults in Singapore: serosurvey among blood donors, 2009.Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1First round of external quality assessment of dengue diagnostics in the WHO Western Pacific Region, 2013Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus.Recombinant Dengue virus protein NS2B alters membrane permeability in different membrane modelsIncreasing Clinical Severity during a Dengue Virus Type 3 Cuban Epidemic: Deep Sequencing of Evolving Viral Populations.DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice.The tetravalent formulation of domain III-capsid proteins recalls memory B- and T-cell responses induced in monkeys by an experimental dengue virus infection.Biological and Molecular Properties of Dengue 2 Strains Isolated during the DHF/DSS Cuban Epidemic, 1981.Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells.
P2860
Q24616798-F9C6CB9A-EB76-4D37-A32C-81088F54BB09Q24647911-CF1ADA74-5991-4053-B8AE-F24DA08236B0Q24652746-9D64712C-41A0-4AFA-AB6F-B079EB619E95Q24701788-A9AD16AD-01CD-4AE4-95C4-D05AFC8A1A29Q26700128-2744BA38-E43C-43AF-ACF2-276E0D354BD6Q27477546-D35135D5-4B2A-49D5-9725-34D65AE2EB95Q27485489-2EA474BA-9689-46CB-B4FC-1813CC2299BBQ27487412-5538016C-CDF4-4CBF-BA63-20E8E361CE29Q27488250-99073391-C028-49C4-AEE3-4AEDA3F292DDQ27490452-E69A9B06-3EF9-4C22-93EE-2BE6E8C4DAF1Q27490882-933D8E9D-F087-478B-9CCE-4084DF2E17C0Q27491036-93F98572-605D-4FFE-A22C-5B7D6BDC3C9DQ27491051-49B6D530-2C50-40EB-A4D0-FFC3FF7A1C9AQ27928048-1918508F-8929-4A8F-850F-46F0B5919FE1Q28298464-568E3702-CDE8-4AA9-8BF5-564A2D4DC080Q29365117-3F68E96B-FC1F-4679-BC1C-92012CB400B3Q33573378-CAF2A2B5-A4CE-486F-8874-E25997ED5276Q33789772-9A8427FD-EB63-442B-891F-2155532CBD07Q33859020-2A671485-E575-45BE-A945-FE1FA3273BEDQ33883807-C8A80CFE-B072-49E2-8E13-73F8447E237CQ33973691-CC6D1CB9-0856-4F20-BD5B-769C9BD45AECQ34423720-36A2A1BA-F825-42A2-800A-0995C8A819EBQ34834135-229A05C5-C930-41E8-A5A4-2734D862F662Q34875480-FD0EE6AE-82DB-4286-9144-D91F13FFA14DQ35049317-36CBAF59-F048-42C2-BD61-29B684DE66C8Q35124289-E99BEDA4-6630-4B80-830F-F9A11B3420D7Q35195545-CDE8D836-44A0-487E-90E0-765693562DEEQ35246149-044FD29E-D68D-4E2A-A13E-58E47710A8BAQ35640994-09D9972C-C5FD-4011-B1D4-EC889C51756BQ35836658-6C1259F8-140E-4863-A6C8-DFE468CCDBB3Q35964842-325CB01E-D4BB-42B0-BD43-D9DE187F0112Q35974066-D9863C63-D42C-4DA2-97C5-85D5C17A1BA9Q36029040-804CDDC2-1CD7-47C1-9DDF-03740184BE0BQ36213311-21FB4F39-0CB8-4818-858D-058706D247EBQ36428473-02E7DFB3-6E1E-40DC-8060-48E986376AFDQ36811991-E3CD203A-86FA-4D56-A1BA-34DDB0589911Q37694852-D7F1F8F2-AE1B-4519-BCD4-2E64D0A89802Q39023330-BB60E653-708B-4A27-926B-B2ACE281DF5DQ39027882-EDF983FC-E60F-45B8-97D2-4D6B835676A2Q39404876-4B47EDE3-EBC3-4145-A414-473AD50AB778
P2860
Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization
description
1985 nî lūn-bûn
@nan
1985 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
name
Simplified plaque reduction ne ...... laque reduction neutralization
@ast
Simplified plaque reduction ne ...... laque reduction neutralization
@en
Simplified plaque reduction ne ...... laque reduction neutralization
@nl
type
label
Simplified plaque reduction ne ...... laque reduction neutralization
@ast
Simplified plaque reduction ne ...... laque reduction neutralization
@en
Simplified plaque reduction ne ...... laque reduction neutralization
@nl
prefLabel
Simplified plaque reduction ne ...... laque reduction neutralization
@ast
Simplified plaque reduction ne ...... laque reduction neutralization
@en
Simplified plaque reduction ne ...... laque reduction neutralization
@nl
P2093
P2860
P3181
P1476
Simplified plaque reduction ne ...... laque reduction neutralization
@en
P2093
D M Morens
N Raybourne
R Putvatana
S B Halstead
P2860
P3181
P407
P577
1985-08-01T00:00:00Z